AtriCure, Inc. (ATRC)
NASDAQ: ATRC · Real-Time Price · USD
27.67
-0.42 (-1.50%)
May 29, 2026, 4:00 PM EDT - Market closed
AtriCure Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 146.17 | 167.43 | 122.72 | 84.31 | 58.1 | 43.65 |
Short-Term Investments | - | - | - | 52.98 | 63.01 | 75.44 |
Cash & Short-Term Investments | 146.17 | 167.43 | 122.72 | 137.29 | 121.11 | 119.09 |
Cash Growth | 46.33% | 36.43% | -10.61% | 13.35% | 1.70% | -51.24% |
Accounts Receivable | 71.31 | 66.65 | 60.34 | 52.5 | 42.69 | 33.02 |
Inventory | 81.14 | 78.49 | 75.34 | 67.9 | 45.93 | 38.96 |
Other Current Assets | 15.07 | 9.94 | 9.43 | 8.56 | 5.48 | 5 |
Total Current Assets | 313.69 | 322.52 | 267.83 | 266.25 | 215.21 | 196.08 |
Net Property, Plant & Equipment | 46.19 | 45.99 | 47.39 | 46.76 | 42.62 | 36.17 |
Other Intangible Assets | 45.64 | 48.03 | 56.47 | 63.99 | 39.34 | 42.99 |
Goodwill | 234.78 | 234.78 | 234.78 | 234.78 | 234.78 | 234.78 |
Long-Term Investments | - | - | - | - | 51.51 | 104.34 |
Other Long-Term Assets | 3.69 | 2.86 | 2.87 | 2.16 | 1.99 | 0.96 |
Total Assets | 643.99 | 654.18 | 609.33 | 613.93 | 585.45 | 615.31 |
Accounts Payable | 30.56 | 25.31 | 25.03 | 27.35 | 19.9 | 18.6 |
Accrued Expenses | 39.5 | 53.09 | 45.59 | 44.68 | 33.02 | 36.09 |
Current Portion of Long-Term Debt | - | - | - | - | 5.47 | - |
Current Portion of Leases | - | - | - | 2.53 | - | - |
Other Current Liabilities | 3.13 | 3.12 | 2.81 | - | - | 1.76 |
Total Current Liabilities | 73.19 | 81.52 | 73.42 | 74.57 | 58.39 | 56.45 |
Long-Term Debt | 61 | 61.87 | 61.87 | 60.59 | 56.83 | 59.74 |
Long-Term Leases | 10.78 | 11.52 | 11.86 | 11.37 | 12.24 | 14.15 |
Other Long-Term Liabilities | 7.32 | 7.34 | 1.21 | 1.23 | 1.23 | 1.22 |
Total Long-Term Liabilities | 79.1 | 80.72 | 74.94 | 73.2 | 70.3 | 75.11 |
Total Liabilities | 152.3 | 162.24 | 148.36 | 147.76 | 128.69 | 131.56 |
Common Stock | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
Additional Paid-in Capital | 904.51 | 904.52 | 863.71 | 824.17 | 787.42 | 764.81 |
Accumulated Other Comprehensive Income | 0.23 | 0.57 | -1.04 | -0.99 | -4.1 | -0.95 |
Retained Earnings | -413.1 | -413.2 | -401.76 | -357.06 | -326.62 | -280.15 |
Shareholders' Equity | 491.69 | 491.94 | 460.97 | 466.17 | 456.75 | 483.76 |
Total Liabilities & Equity | 643.99 | 654.18 | 609.33 | 613.93 | 585.45 | 615.31 |
Total Debt | 71.78 | 73.38 | 73.73 | 74.49 | 74.55 | 73.89 |
Net Cash (Debt) | 74.38 | 94.05 | 49 | 62.79 | 46.57 | 45.2 |
Net Cash Growth | -20.91% | 91.95% | -21.97% | 34.85% | 3.02% | -74.70% |
Net Cash Per Share | 1.54 | 1.97 | 1.04 | 1.36 | 1.02 | 0.98 |
Book Value | 491.69 | 491.94 | 460.97 | 466.17 | 456.75 | 483.76 |
Book Value Per Share | 10.16 | 10.30 | 9.82 | 10.07 | 9.99 | 10.51 |
Tangible Book Value | 211.27 | 209.13 | 169.72 | 167.4 | 182.63 | 205.98 |
Tangible Book Value Per Share | 4.37 | 4.38 | 3.61 | 3.61 | 3.99 | 4.47 |